Ozempic is whats known as a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that also includes liraglutide (Victoza), dulaglutide (Trulicity), and exenatide (Bydureon)
"As part of an extension trial published a year later, participants regained an average of two-thirds of the weight they shed within 12 months of discontinuing the drug." Within 12 months of discontinuing the drug, participants regained an average of two-thirds of the weight they shed
To view a copy of this licence, visit About this article Cite this article Ali, N.H., Al-kuraishy, H.M., Al-Gareeb, A.I
No complicated preparation has been required
However, there is absolutely no regulation on how these products are used after theyre purchased, and its likely very little research is being done
Doaei et al., 2021